BioFinlandin jäsen

Uniogen is a global pioneer in clinical diagnostics, point-of-care testing, and instrumentation for life sciences. With our unique point-of-care tests, we provide patients and healthcare with faster, easier, and more cost-effective diagnostics of infectious diseases, cardiovascular diseases, and cancer—among others. Our mission is to enable diagnosis and care for patients at the first appointment.The GenomEra® CDX system by Uniogen provides a powerful tool for running molecular diagnostics for infectious diseases routinely and cost-efficiently without compromising assay reliability and quality. Uniogen is a specialist in immunoassays and antibody tests, and your trusted partner for custom IVD assay development. Uniogen is your experienced and easy-to-work-with partner for OEM plate readers (original equipment manufacturing). Our Upcon® labeling system, coupled with state-of-the-art laboratory instruments and flexible software, brings high sensitivity and superior performance to point-of-care testing. Uniogen was established when Abacus Diagnostica, Kaivogen and Labrox joined forces in the beginning of 2022. The company is headquartered in Turku, Finland, and employs close to 100 life science professionals. Uniogen’s products are sold in approximately 100 countries around the world. In 2021, the combined annual net sales of the three companies forming Uniogen was around 15 million euros.